MedMiraOct 33 min readMedMira Announces the appointment of Vice President of Commercial OperationsHalifax, Nova Scotia, October 3, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) today announced the appointment of Nicole Crenshaw as...
MedMiraAug 135 min readClinical Trials to get Underway with Multiplo® Complete Syphilis (TP/nTP) Antibody Test - A Potential Game Changer to Address Syphilis Health Crisis in CanadaHalifax, Nova Scotia, 13 August, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces it will conduct full clinical trials for its...
MedMiraJun 121 min readMiriad MultiLinx - One Test, More AnswersIntroducing MedMira's latest product now available anywhere for Tissue and Eye Banks: Miriad MultiLinx: One Test, More Answers. The...
MedMiraApr 302 min readMedMira Announces the Hire of Vice President of Business DevelopmentHalifax, Nova Scotia,30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their...
MedMiraApr 191 min readInnovation made easyWith MedMira's patented RVF Technology, there are a myriad of possibilities: As an example, our latest custom made product for one of our...
MedMiraMar 134 min readMedMira Receives Canadian Patent for its Unique Quantitative Diagnostic SystemHalifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent...